Navigation Links
The Leukemia & Lymphoma Society and Cleveland Clinic Taussig Cancer Institute Announce Groundbreaking Partnership to Accelerate Drug Approvals
Date:10/9/2007

WHITE PLAINS, N.Y., Oct. 9 /PRNewswire/ -- In an effort to increase access and participation in clinical trials among adult blood cancer patients, The Leukemia & Lymphoma Society and Cleveland Clinic Taussig Cancer Institute have launched a groundbreaking partnership, The Clinical Trial Center for Hematologic Malignancies.

This innovativecollaboration is a unique approach to making blood cancer clinical trials available to patients in their community so they can easily have access to the newest treatments for leukemia, lymphoma and myeloma.

"The challenge of recruiting patients to participate in clinical trials is one of the greatest obstacles to getting new drugs approved," said Louis DeGennaro, Ph.D., the Society chief scientific officer. "In fact, less than 5 percent of adult cancer patients nationally participate in trials."

Other major barriers to recruiting patients into clinical trials include patients' reluctance to leave their own doctors and the requirement to travel to major cities outside of their communities to get treatments and participate in trials. Patients also often view trials as risky.

Cleveland Clinic is uniquely structured to work with the Society to overcome these hurdles. Taussig has 45 oncologists at its main campus and another 20 on staff throughout its regional hospitals in the Cleveland metropolitan area. Patients can easily participate in the center's clinical trials while still remaining with their own doctors. The ability to remain with their own doctors will also go a long way toward alleviating patients' fears about participating in the trials. As a result of the broad reach into the community, the clinic has access to a large volume of patients, so recruiting for clinical trials will be much easier. Patients will have access to promising new therapies and will receive far greater supervision under highly controlled conditions than they would under normal treatment circumstances.

"The beauty of t
'/>"/>

SOURCE Leukemia & Lymphoma Society
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Nuvelo Announces Publication of Preclinical Study Results Demonstrating the Potential of NTB-A as a New Target for Leukemia and Lymphomas
2. Dasatinib Shows High Early Response Rate as First Treatment for Chronic Myelogenous Leukemia, M. D. Anderson Researchers Report
3. Promising Results with Epratuzumab and Chemotherapy in Children with Acute Lymphoblastic Leukemia
4. ZymoGenetics Reports Results From Atacicept Phase 1b Clinical Trial in B-Cell Chronic Lymphocytic Leukemia
5. Major Gene Study Uncovers Secrets of Leukemia
6. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
7. Based on Up to 6 Years of Follow-Up, Biovest Announces Favorable Interim Blinded Data for Fast-Tracked Pivotal Phase 3 Clinical Trial of BiovaxID Anti-Cancer Vaccine for Non-Hodgkins Lymphoma
8. Fractionated Radioimmunotherapy With (90)Y-epratuzumab in Non-Hodgkins Lymphoma Appears Safe and Active in a Phase I/II Study
9. Favrille Announces Data From Phase 2 Clinical Trial of FavId for Indolent B-Cell Non-Hodgkins Lymphoma in Europe
10. Gloucester Pharmaceuticals Reports Positive Interim Phase II Data on Romidepsin for T-Cell Lymphomas at the 2007 American Society of Clinical Oncology Annual Meeting
11. Ontak (denileukin diftitox) Achieves 49.1% Overall Response Rate in Phase III Trial of Cutaneous T-Cell Lymphoma (CTCL)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... Aug. 28, 2015 ... the addition of the "Investigation Report on ... offering. Originally discovered by Welfide (Mitsubishi ... Industries, Ltd) as an inflammatory drug, pranoprofen was ... Co., Ltd under the trade name of pranopulin ...
(Date:8/28/2015)... , Aug. 28, 2015 ... addition of the "Investigation Report on China,s Tobramycin ... Tobramycin is a traditional antibiotic whose eye drop and ... treatment of potential infection or inflammation caused by eye ... are able to produce tobramycin, among which ...
(Date:8/28/2015)... , Aug. 28, 2015 ... announced the addition of the "Investigation Report ... their offering. Developed by AstraZeneca plc, ... an important drug for the treatment of schizophrenia. ... quetiapine was listed in the Catalogue of Drugs ...
Breaking Medicine Technology:Investigation Report on China's Pranoprofen Market, 2010-2019 2Investigation Report on China's Tobramycin Market, 2015-2019 2China Quetiapine Market Investigation Report 2010-2019 2
... Genomics announced today that,the company entered into a ... (JHU) to commercialize products that identify,patients at risk ... a suite of,issued and pending JHU patents covering ... (IGF2). Orion,s simple blood-based risk,assessment test is being ...
... , - Data Published in the British ... Negative Impact on Overall Survival or Tumour,Progression, ... controlled,studies in 2,301 cancer patients shows that treating ... on survival, tumour,progression or deaths caused by blood ...
Cached Medicine Technology:Orion Genomics Gains Exclusive Worldwide Rights to the IGF2 Gene for Colorectal Cancer Risk Testing Through Licensing Agreement With Johns Hopkins University 2New Meta-Analysis Confirms Safety Profile for NeoRecormon in Treating Anaemia in Cancer Patients 2
(Date:8/30/2015)... Fl (PRWEB) , ... August 30, 2015 , ... ... Executive Vice President Jeff Fernandez will lead the expansion of global cosmeceutical and ... and skin care experience having spent the last 25 years working in operations, ...
(Date:8/29/2015)... ... August 30, 2015 , ... Rio Salado College President ... the college’s Vice President of Strategic Initiatives and Information Services. O’Shea, who has served ... college expand its reach and impact through innovative technologies and strategies. , “I am ...
(Date:8/29/2015)... ... August 29, 2015 , ... On Saturday, September 19, ... Applied Research Foundation (Meso Foundation) will present an educational program titled “Asbestos and ... and lasts through 9:30 PM (doors open at 6:45pm) at Calvary United Methodist Church, ...
(Date:8/29/2015)... ... August 29, 2015 , ... ... extend and improve the lives of patients, according to a newly published report. ... to read the full article. , The authors of the new paper ...
(Date:8/29/2015)... York, NY (PRWEB) , ... August 29, 2015 , ... ... unofficial end of summer (which astronomically, officially ends on September 22nd this year). For ... summer-induced cyber security hangovers linger on which could prove far more costly than a ...
Breaking Medicine News(10 mins):Health News:NPI Executive Vice President Leads Cosmeceutical Expansion 2Health News:Rio Salado College Appoints New Vice President of Strategic Initiatives and Information Services 2Health News:Mesothelioma Applied Research Foundation to Hold Educational Class About Asbestos and Mesothelioma Prevention 2Health News:Top Mesothelioma Researchers Highlight Targeted Therapies in New Report, According to Surviving Mesothelioma 2Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 2Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 3Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 4
... of North Carolina at Chapel Hill School of Medicine ... large clinical study to evaluate the role played by ... study, which was part of the Johnston County Osteoarthritis ... who inherited a specific pattern of genetic variations in ...
... sunless tanning products, and an intervention promoting these products ... and sunburns among adult women, according to two reports ... , one of the JAMA/Archives journals. Ultraviolet radiation ... category and is the most common avoidable cause of ...
... to any length to try to become part of a ... eating something dicey, or doing illicit drugs, according to a ... "Social exclusion prompts people to use money and ... Mead (Tilburg University), Roy F. Baumeister (Florida State University), Tyler ...
... By Kathleen Doheny HealthDay Reporter , ... studies may help breast cancer patients and their ... after mastectomy. One study finds that about ... having had a mastectomy with immediate reconstruction develop ...
... HealthDay Reporter , MONDAY, Sept. 20 (HealthDay News) -- ... of hearings Monday on whether to recommend approval of ... the advisers recommend approval, it would mark the first ... America,s dinner plates and restaurant menus. Currently, genetically modified ...
... College of Law at Arizona State University has been ... Law Network, which launches today to provide legal and ... challenges such as food safety, health reform and emergency ... Program (PHLPP) received a $1.325 million grant from the ...
Cached Medicine News:Health News:UNC researchers identify genetic patterns that may predict osteoarthritis 2Health News:UNC researchers identify genetic patterns that may predict osteoarthritis 3Health News:Use of sunless tanning products common in teens, may encourage sun safety in women 2Health News:Use of sunless tanning products common in teens, may encourage sun safety in women 3Health News:Money, drugs and chicken feet? What consumers will do for social acceptance 2Health News:Breast Reconstruction After Mastectomy: Now or Later? 2Health News:Breast Reconstruction After Mastectomy: Now or Later? 3Health News:FDA Advisers Weigh Approval of Genetically Modified Salmon 2Health News:FDA Advisers Weigh Approval of Genetically Modified Salmon 3Health News:11-state regional Public Health Law Network office to be established at ASU College of Law 2Health News:11-state regional Public Health Law Network office to be established at ASU College of Law 3
This handy reference contains all of the essential information that surgical residents and medical students need to have at their fingertips for day-to-day patient care....
... involved with healthcare decisions to keep up ... in their field of interest - a ... the volume of evidence increases. Cochrane Reviews ... single source available for continually updated evidence-based ...
... is a combination of the Medical Spanish pocket ... for PDA. The first part of Medical Spanish ... the Spanish language, i.e. pronunciation, common words and ... and medical terminology. The second part is organized ...
This portable resource provides definitions for medical acronyms and abbreviations....
Medicine Products: